Αρχική World News New on NCI Websites for June 2018

New on NCI Websites for June 2018

June 25, 2018, by NCI Staff

Credit: National Cancer Institute

NCI’s collection of cancer information products is constantly growing, so periodically we provide updates on new and updated content of interest to the cancer community.

New Video Explains Different Types of Immunotherapy

Immunotherapy uses the body’s immune system to fight cancer. This animation explains three types of immunotherapy used to treat cancer: nonspecific immune stimulation, T-cell transfer therapy, and immune checkpoint inhibitors.

Infographic Explains NCI Formulary

This new infographic helps explain the NCI Formulary, a public–private partnership between NCI and pharmaceutical and biotechnology companies that provides NCI-funded institutions rapid access to therapies for use in cancer clinical trials or laboratory research.

New Videos: Glioblastoma Clinical Trial

NCI’s Center for Cancer Research (CCR) serves as the lead institution for the Brain Tumor Trials Collaborative (BTTC), a group of researchers and institutions dedicated to finding better therapies for the treatment of patients with brain tumors. The BTTC page now features a pair of videos about one of the collaborative’s clinical trials.

New Video: The Cancer Genome Atlas Legacy

This video celebrates the accomplishments and contributions of The Cancer Genome Atlas (TCGA), a landmark program in cancer genomics. As the TCGA program ends, the video relives the driving forces behind the program’s creation, innovations employed in its execution, and major impacts the program has had on cancer research.

Rare Cancer Statistics | Did You Know? Video

This new video from NCI explains why more than 500 cancer types are considered “rare,” as well as the incidence and survival trends for these rare cancers.

Infographic Illustrates Genetic Changes and Cancer

Mutations in certain genes can cause normal tissue to become cancerous. This new infographic illustrates how genes make proteins and describes the types of genetic mutations that may lead to cancer.

Eating Hints Publication Updated

The updated publication Eating Hints: Before, During, and After Cancer Treatment explains why people undergoing treatment for cancer may have eating problems, identifies the types of eating problems they might encounter, and suggests ways to manage them.

Latest issue of DCEG Linkage newsletter available

NCI’s Division of Cancer Epidemiology and Genetics (DCEG) has published the latest issue of its Linkage newsletter. The issue features Of Microbes and Men: Advancing Epidemiologic Research on the Human Microbiome and an article on medical radiation exposures and thyroid cancer, by DCEG’s Cari Kitahara, Ph.D. The issue includes highlights on the latest scientific publications and updates on staff achievements, including recognition of DCEG founding director Joseph F. Fraumeni, Jr., M.D., by NIH’s scientific directors.

New in Visuals Online

NCI’s Visuals Online website has added more than 50 new images since the beginning of 2018, including factoids from the Annual Report to the Nation, new anatomical drawings of cancer at various stages and locations, and new infographics.

New Animation: Paying for Clinical Trials

The latest in NCI’s series of videos about clinical trials, this animation explains the different types of costs related to taking part in a clinical trial and who is expected to pay for which costs.

Rectal Cancer and Adult Brain Tumor Facebook Live Videos

On March 29, NCI hosted a Facebook Live event on rectal cancer, which included a discussion on current treatments and ongoing research. The event featured Carmen Allegra, M.D., of NCI’s Cancer Therapy Evaluation Program (CTEP) and University of Florida Health; Deborah Schrag, M.D., M.P.H., of Dana-Farber Cancer Institute; and Andrea Denicoff, R.N., M.S., also of CTEP.

And on May 25, NCI conducted a Facebook Live event about adult brain and spine cancers with Mark Gilbert, M.D., and Terri Armstrong, Ph.D., of NCI’s Neuro-Oncology Branch. The event was moderated by David Arons, chief executive officer of the National Brain Tumor Society.

Fact Sheets Revised

NCI’s nearly 100 fact sheets address a wide array of cancer topics, including risk factors, prevention, treatment, and supportive care. Several of these fact sheets have been revised recently, including:

Cancer Disparities Content Updated

The term “cancer disparities” refers to differences in cancer outcomes (for example, number of cancer cases, related health complications) across population groups. NCI has recently updated its information about cancer disparities.

New Resource on Access to Experimental Cancer Drugs

A new page explains the different ways cancer patients can get access to experimental drugs that have been approved for testing in humans but cannot yet be advertised, sold, or prescribed.

Updates to Stories of Discovery

The Stories of Discovery highlight NCI’s role in landmark developments in cancer prevention and treatment. Over the past few months, NCI has updated several of these articles, including:

Cancer Statistics Overview Updated

Cancer statistics are used to describe cancer’s population-wide impact and provide a picture in time of the burden of cancer on society. NCI has updated its overview of cancer statistics with new data from the institute’s most recent SEER Cancer Statistics Review.

Emergency Resources for the Cancer Community

Natural or manmade disasters can disrupt care for cancer patients in the affected communities. NCI has updated its resources for cancer patients, health care providers, and cancer researchers affected by these emergencies.



Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like

Διαβαστε Επίσης


ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...

Καρκίνος: Ευεργετική για τους καρκινοπαθείς η άσκηση

Σημαντικά ωφέλη προσφέρει η άσκηση, ακόμη και σε ασθενείς με καρκίνο. Οι περισσότεροι ασθενείς αγνοούν τα οφέλη που μπορεί να έχει γι’ αυτούς η συχνή...

Prostate Cancer

The article is provided by Scientific Communications Officer of NIPD Genetics, Ms Marina Charitou (MSc) Prostate Cancer Awareness Prostate cancer is the second most common cancer...
- Advertisment -

Ροή Ειδήσεων

ACHIEVE-2 Results of Oxaliplatin-Based Adjuvant Chemotherapy in Asian Patients with High-Risk Stage II Colon Cancer

The Asian researchers reported on 25 October 2020 in the Annals of Oncology that 3-month of combination therapy for adjuvant treatment of high-risk stage...

GreaterGood’s Mask Donations Are Helping LA Family Housing Keep Homeless People Safe

Due to the COVID-19 pandemic, people everywhere are uncertain about the future of their health, safety, and economic security. Homeless people and those who...

How I Found a Meaningful Career After Cancer

Jacky Costello is the founder and owner of a house cleaning company serving the greater Tampa Bay area in Florida. Through her company's partnership with...

Radiopharmaceuticals: Radiation Therapy Enters the Molecular Age

October 26, 2020, by NCI Staff Radiopharmaceuticals consist of a radioactive molecule, a targeting molecule, and a linker that joins the two. Credit: National Cancer Institute The...

FDA Grants Regular Approval to Venetoclax in Combination for Untreated Acute Myeloid Leukaemia

On 16 October 2020, the US Food and Drug Administration (FDA) granted regular approval to venetoclax (VENCLEXTA ®, AbbVie Inc. and Genentech Inc.) in...

EMA Recommends Granting a Marketing Authorisation for Lenalidomide Mylan

On 15 October 2020, the European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting...